An Ethical Allocation Scheme for Scarce Gene Therapies in Sickle Cell Disease andTransfusion-Dependent β-Thalassemia

Research

May 1

Written By Christine Briscoe

Authors: Amar Kelkar, Maureen Achebe, and Andrew Hantel

Published:April 24, 2025

Christine Briscoe

Is the early use of ketamine effective as an opioid sparing adjunct for treating pain in sickle cell disease patients?

Screen of the ReFRAME Compound Library for Therapeutic Agents to Prevent Red Blood Cell Sickling Using an Improved High Throughput Sickling Assay